Pinnacle Atlas Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: price-focused shoppers who want low flat-rate compounded semaglutide or tirzepatide
Price is where Pinnacle Atlas scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Pinnacle Atlas is a Sacramento-based telehealth platform that connects adults with independent licensed clinicians for compounded semaglutide and tirzepatide, alongside hormone, peptide and NAD+ programs. Medication comes from partner U.S. compounding pharmacies with free shipping, and the company says one flat monthly price covers every dose. Its plan picker lists semaglutide at $139 a month and tirzepatide at $145 a month.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Pinnacle Atlas
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Luvo Health
Best for: compounded and brand GLP-1s, oral tablets and microdosing on one public price list
Editorial score · methodology
Editorial score · methodology
Pinnacle Atlas at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $139/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Pinnacle Atlas
Each dimension is scored algorithmically from Pinnacle Atlas’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.1/10At $139/mo, Pinnacle Atlas runs about 22% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.7/10Pinnacle Atlas offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.4/10Online intake and platform experience — app/portal-based, consult included in the price; 6 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.7/10Pinnacle Atlas's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.5/10Pinnacle Atlas provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Pinnacle Atlas review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $139–$145/mo across 2 dose/plan tiers — checked October 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Pinnacle Atlas
We walked Pinnacle Atlas’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Goal question: the "Check Eligibility" button opens a one-question-per-screen assessment that starts with "What would you like support with?" (long-term health, feeling better day to day, confidence and appearance, or reducing health risks).
- 2Activity level: the next screen asks how active you usually are. We stopped here, since the following screens collect health and contact details.
- 3The rest of the same public assessment, which we did not fill in, asks for your height and weight, agreement to the Terms, Privacy Policy and Telehealth Consent, a U.S. phone number and a shipping address.
- 4Only then does a "Select your treatment" screen list the plans and prices, and choosing one leads to a payment page. The company says a licensed provider finalizes your plan before anything ships.
- Before the assessment, the only price is the homepage's "Plans from $139/mo · confirmed after provider review"; the treatment pages say "Available by consultation" instead of a price.
- The plan picker lists compounded semaglutide at $139 a month (struck-through $249), tirzepatide at $145 (struck-through $299), a GLP-1 microdose plan at $199 and an oral GLP-1 at $229, under the line "Same price · All dosages · No hidden fees · Everything included."
- The homepage also shows "$149 to start /mo", which matches none of those plans.
- The terms say your card is charged immediately and every 30 days after that, and that you get a refund if the prescriber declines to prescribe.
- Neither a lab requirement nor a video visit is stated in the public funnel; the homepage mentions sharing bloodwork "if you have it."
- Support is by phone and email, with no published hours. We did not take the medication and cannot speak to outcomes.
Pinnacle Atlas customer support
- Phone
- (626) 627-5349
GLP-1 medications Pinnacle Atlas offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Shown in the plan picker as $139/mo next to a struck-through $249; the site doesn't say whether $139 is an introductory or ongoing rate.
Shown in the plan picker as $145/mo next to a struck-through $299; the site doesn't say whether $145 is an introductory or ongoing rate.
Ready to get started?
Plans and promotions change often — check Pinnacle Atlas's current pricing and active discounts before you decide.
What we like
- Low listed prices: compounded semaglutide at $139 a month and tirzepatide at $145 a month
- The company says one price covers every dose, with no consultation fees or dose-change surcharges
- Nothing is charged if a provider doesn't approve you, and you're refunded if the prescriber declines
- Medication, the clinician's care and free shipping are bundled in one monthly price
- Support by phone and email, plus secure messaging with your care team
Watch-outs
- Plan prices only appear after a multi-step health questionnaire that asks for your phone number and address
- The lower prices are shown next to struck-through $249 and $299 prices, with no word on how long they last
- The homepage advertises "$149 to start" a month, a price that doesn't match any plan in the picker
- The prescribing medical group and compounding pharmacies are not named, and there's no LegitScript certification
- A new company: its terms are dated June 2026, and it doesn't list which states it serves
- "As featured in" CNN, Forbes and New York Times logos aren't linked to any coverage
- The FAQ asks for 30 days' notice to cancel, while the terms allow canceling up to 48 hours before a charge
Is Pinnacle Atlas worth it?
What Pinnacle Atlas is selling, in one line, is price-focused shoppers who want low flat-rate compounded semaglutide or tirzepatide. It runs $139/month at every dose — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Beyond the medication itself, Pinnacle Atlas doesn't charge you until you're approved.
How much Pinnacle Atlas actually costs
Compounded semaglutide runs $139/month and compounded tirzepatide runs $145/month.
That puts Pinnacle Atlas below the roughly $179 median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide) — a real cost advantage.
For a direct comparison, Live Vital runs semaglutide and tirzepatide from $130/month — worth pricing against Pinnacle Atlas before you commit.
Medications: what Pinnacle Atlas prescribes
Pinnacle Atlas prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Pinnacle Atlas is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $139/month is below the roughly $179 median we track across the category (each program's lowest listed ongoing monthly price).
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Pinnacle Atlas earns its place on the shortlist mainly on price: at $139/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Pinnacle Atlas scores best in our breakdown.
Ready to start with Pinnacle Atlas?
From $139/mo. See current pricing and start your free consultation.
Pinnacle Atlas might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Pinnacle Atlas vs…
Pinnacle Atlas scores7.2/10
Side-by-side pricing, medications and scores — pick a matchup.
Pinnacle Atlas vs Amazon One Medical
Amazon One Medical scores 8.5/10
Pinnacle Atlas vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Pinnacle Atlas review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pinnacle Atlas's current pricing
Plans from $139/mo. Start your free consultation to check eligibility and today's price.